Carl Chan is a seasoned professional in equity investment, currently serving in a Growth Equity role at Thoma Bravo since 2013. With extensive experience in the software and technology sectors, Carl has led significant investment rounds, including a $123 million Series E for Alation, a $70 million Series C for AppOmni, and a $100 million Series D for Imply. Other notable investments include co-leading a $420 million investment in project44 and a $200 million Series C for Paradox. Carl holds an MBA from The Wharton School and a Bachelor of Commerce in Finance from the University of Calgary.
This person is not in the org chart
This person is not in any teams
This person is not in any offices